RICHARD A. LEWIS, M.D.
Medical Practice at Fannin St, Houston, TX
License number
Texas F4930
Category
Medical Practice
Type
Ophthalmology
Address
Address
6550 Fannin St SUITE 1501, Houston, TX 77030
Phone
(713) 798-6100
(713) 798-4231 (Fax)
(713) 798-4231 (Fax)
Organization information
See more information about RICHARD A. LEWIS at bizstanding.comBaylor Ophthalmology - Richard A Lewis MD
1977 Butler Blvd, Houston, TX 77030
Categories:
Ophthalmology Physicians & Surgeons
Phone:
(713) 798-6100 (Phone)
THE RICHARD LEWIS TRAVEL SERVICE INC
PO Box 1971, Houston, TX 77251
Status:
Inactive
Doing business as:
The Richard Lewis Travel Service, Inc
Registration:
Mar 4, 1974
State ID:
0003561606
Business type:
Foreign For-Profit Corporation
Entity State:
OH
Agent:
Martin Shretter,Foley's DEPARTMENT STORE, Houston, TX 77001 (Physical)
TIN:
30002097993
Professional information
Chaplin At Victim Relief Ministeries
Position:
PRESIDENT at RWL CONSTRUCTION, INC., CHAPLIN at VICTIM RELIEF MINISTERIES, PASTOR at FIRST BAPTIST CHURCH. MATAGORDA, TX
Location:
Houston, Texas Area
Industry:
Construction
Work:
RWL CONSTRUCTION, INC.
-
PRESIDENT
VICTIM RELIEF MINISTERIES
since Oct 2008
-
CHAPLIN
FIRST BAPTIST CHURCH. MATAGORDA, TX
since May 2006
-
PASTOR
Richard A Lewis, Houston TX
Specialties:
Ophthalmologist
Address:
1 Baylor Plz, Houston, TX 77030
6550 Fannin St, Houston, TX 77030
1977 Butler Blvd, Houston, TX 77030
6550 Fannin St, Houston, TX 77030
1977 Butler Blvd, Houston, TX 77030
Education:
University of Michigan - Master of Science in Electrical Engineering
University of Michigan, Medical School - Doctor of Medicine
University of Michigan Health System - Fellowship - Retina
University of Michigan Health System - Residency - Ophthalmology
University of Michigan Health System - Internship - Internal Medicine
University of Michigan, Medical School - Doctor of Medicine
University of Michigan Health System - Fellowship - Retina
University of Michigan Health System - Residency - Ophthalmology
University of Michigan Health System - Internship - Internal Medicine
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology
Hse At Shell
Position:
HSE at Shell
Location:
Houston, Texas Area
Industry:
Oil & Energy
Work:
Shell
-
HSE
Owner, American Enerpower
Position:
Owner at American Enerpower
Location:
Houston, Texas Area
Industry:
Management Consulting
Work:
American Enerpower
-
Owner
91B At Us Army
Position:
91b at US Army
Location:
Houston, Texas Area
Industry:
Military
Work:
US Army
-
91b
Dr. Richard A Lewis, Houston TX - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
Baylor Eye Physicians and Sgns
1977 Butler Blvd, Houston 77030
(713) 798-6100 (Phone)
6550 Fannin St STE 1501, Houston 77030
(713) 798-6100 (Phone), (713) 798-4231 (Fax)
7200 Cambridge St STE B, Houston 77030
(713) 798-6100 (Phone)
Texas Childrens Hospital General
6701 Fannin St STE 1560, Houston 77030
(832) 822-4280 (Phone)
1977 Butler Blvd, Houston 77030
(713) 798-6100 (Phone)
6550 Fannin St STE 1501, Houston 77030
(713) 798-6100 (Phone), (713) 798-4231 (Fax)
7200 Cambridge St STE B, Houston 77030
(713) 798-6100 (Phone)
Texas Childrens Hospital General
6701 Fannin St STE 1560, Houston 77030
(832) 822-4280 (Phone)
Certifications:
Ophthalmology, 1976
Awards:
Healthgrades Honor Roll
Languages:
English, French
Education:
Medical School
University Of Michigan Medical School
Graduated: 1969
University Mi Hospital
Graduated: 1970
Graduated: 1974
Bascom Palmer Eye Institute
Graduated: 1975
Graduated: 1971
University Of Michigan Medical School
Graduated: 1969
University Mi Hospital
Graduated: 1970
Graduated: 1974
Bascom Palmer Eye Institute
Graduated: 1975
Graduated: 1971
Diagnosis And Treatment Of Medical Conditions Associated With Defective Nfkappa B(Nf- B) Activation
US Patent:
6824972, Nov 30, 2004
Filed:
May 22, 2001
Appl. No.:
09/863049
Inventors:
Sue J. Kenwrick - Cambridge, GB
Hayley Woffendin - Cambridge, GB
Arnold Munnich - Paris, FR
Asmae Smahi - Saint Ouen, FR
Alain Israel - Paris, FR
Annemarie Poustka - Heidelberg, 69120, DE
Nina Heiss - Heidelberg, 69115, DE
Michele DUrso - Naples, IT
Richard A. Lewis - Houston TX
David L. Nelson - Houston TX
Swaroop Aradhya - Houston TX
Moise Levy - Houston TX
Hayley Woffendin - Cambridge, GB
Arnold Munnich - Paris, FR
Asmae Smahi - Saint Ouen, FR
Alain Israel - Paris, FR
Annemarie Poustka - Heidelberg, 69120, DE
Nina Heiss - Heidelberg, 69115, DE
Michele DUrso - Naples, IT
Richard A. Lewis - Houston TX
David L. Nelson - Houston TX
Swaroop Aradhya - Houston TX
Moise Levy - Houston TX
Assignee:
Baylor College of Medicine - Houston TX
Cambridge University Technical Services Limited - Cambridge
Consiglio Nazionale Delle Richerche - Rome
INSERM - Cedex 13
LInstitut Pasteur - Paris
Annemarie Poustka - Heidelberg
Nina Heiss - Heidelberg
Cambridge University Technical Services Limited - Cambridge
Consiglio Nazionale Delle Richerche - Rome
INSERM - Cedex 13
LInstitut Pasteur - Paris
Annemarie Poustka - Heidelberg
Nina Heiss - Heidelberg
International Classification:
C12Q 100
US Classification:
435 4, 435 5, 435 6, 435 7, 536 231
Abstract:
Incontinentia Pigmenti (IP) is a neurocutaneous genodermatosis that segregates as an X-linked dominant disorder with a high probability of prenatal male lethality. A locus in Xq28 containing NF- B Essential Modulator, a gene product involved in the activation of NF-kB and central to many pro-inflammatory and apoptotic pathways, contains mutations in the majority of cases of IP. Disclosed are methods, compositions and kits directed to a defect in a NF- B related disease such as IP.
Methods Of Gene Therapy Using Nucleic Acid Sequences For Atp-Binding Cassette Transporter
US Patent:
8129353, Mar 6, 2012
Filed:
Dec 11, 2006
Appl. No.:
11/636909
Inventors:
Rando Allikmets - Frederick MD, US
Kent L. Anderson - Houston TX, US
Michael Dean - Frederick MD, US
Mark Leppert - Salt Lake City UT, US
Richard A. Lewis - Houston TX, US
Yixin Li - Houston TX, US
James R. Lupski - Houston TX, US
Jeremy Nathans - Baltimore MD, US
Amir Rattner - Baltimore MD, US
Noah F. Shroyer - Houston TX, US
Nanda Singh - Salt Lake City UT, US
Philip Smallwood - Woodbine MD, US
Hui Sun - Baltimore MD, US
Kent L. Anderson - Houston TX, US
Michael Dean - Frederick MD, US
Mark Leppert - Salt Lake City UT, US
Richard A. Lewis - Houston TX, US
Yixin Li - Houston TX, US
James R. Lupski - Houston TX, US
Jeremy Nathans - Baltimore MD, US
Amir Rattner - Baltimore MD, US
Noah F. Shroyer - Houston TX, US
Nanda Singh - Salt Lake City UT, US
Philip Smallwood - Woodbine MD, US
Hui Sun - Baltimore MD, US
Assignee:
Baylor College of Medicine - Houston TX
John Hopkins University - Baltimore MD
The United States of America as represented by the Secretary, Department of Health and Human Services - Washington DC
University of Utah Research Foundation - Salt Lake City UT
John Hopkins University - Baltimore MD
The United States of America as represented by the Secretary, Department of Health and Human Services - Washington DC
University of Utah Research Foundation - Salt Lake City UT
International Classification:
A61K 48/00, A61K 38/43, C07H 21/02
US Classification:
514 44R, 536 231, 424 941
Abstract:
The present invention provides nucleic acid and amino acid sequences of an ATP binding cassette transporter and mutated sequences thereof associated with macular degeneration. Methods of detecting agents that modify ATP-binding cassette transporter comprising combining purified ATP binding cassette transporter and at least one agent suspected of modifying the ATP binding cassette transporter an observing a change in at least one characteristic associated with ATP binding cassette transporter. Methods of detecting macular degeneration is also embodied by the present invention.
Methods Of Gene Therapy Using Nucleic Acid Sequences For Atp-Binding Cassette Transporter
US Patent:
7192579, Mar 20, 2007
Filed:
Jan 3, 2003
Appl. No.:
10/336219
Inventors:
Rando Allikmets - Frederick MD, US
Kent L. Anderson - Houston TX, US
Michael Dean - Frederick MD, US
Mark Leppert - Salt Lake City UT, US
Richard A. Lewis - Houston TX, US
Yixin Li - Houston TX, US
James R. Lupski - Houston TX, US
Jeremy Nathans - Baltimore MD, US
Amir Rattner - Baltimore MD, US
Noah F. Shroyer - Houston TX, US
Nanda Singh - Salt Lake City UT, US
Philip Smallwood - Woodbine MD, US
Hui Sun - Baltimore MD, US
Kent L. Anderson - Houston TX, US
Michael Dean - Frederick MD, US
Mark Leppert - Salt Lake City UT, US
Richard A. Lewis - Houston TX, US
Yixin Li - Houston TX, US
James R. Lupski - Houston TX, US
Jeremy Nathans - Baltimore MD, US
Amir Rattner - Baltimore MD, US
Noah F. Shroyer - Houston TX, US
Nanda Singh - Salt Lake City UT, US
Philip Smallwood - Woodbine MD, US
Hui Sun - Baltimore MD, US
Assignee:
Baylor College of Medicine - Houston TX
Johns Hopkins University - Baltimore MD
University of Utah Research Foundation - Salt Lake City UT
United States of America, Represented by the Secretary, Department of Health and Human Services, c/o National Institute of Health - Washington DC
Johns Hopkins University - Baltimore MD
University of Utah Research Foundation - Salt Lake City UT
United States of America, Represented by the Secretary, Department of Health and Human Services, c/o National Institute of Health - Washington DC
International Classification:
A01N 63/00, A01N 43/04, C12P 21/06, C12N 5/00, C12N 15/00, C12N 15/63, C07H 21/04
US Classification:
424 931, 424 932, 435 691, 4353201, 435325, 435455, 514 44, 536 231, 536 235
Abstract:
The present invention provides nucleic acid and amino acid sequences of an ATP binding cassette transporter and mutated sequences thereof associated with macular degeneration. Methods of detecting agents that modify ATP-binding cassette transporter comprising combining purified ATP binding cassette transporter and at least one agent suspected of modifying the ATP binding cassette transporter an observing a change in at least one characteristic associated with ATP binding cassette transporter. Methods of detecting macular degeneration is also embodied by the present invention.
Methods Of Gene Therapy Using Nucleic Acid Sequences For Atp-Binding Cassette Transporter
US Patent:
2012004, Feb 16, 2012
Filed:
Jun 2, 2011
Appl. No.:
13/151375
Inventors:
Rando Allikmets - Frederick MD, US
Kent L. Anderson - Houston TX, US
Michael Dean - Frederick MD, US
Mark Leppert - Salt Lake City UT, US
Richard A. Lewis - Houston TX, US
Yixin Li - Houston TX, US
James R. Lupski - Houston TX, US
Jeremy Nathans - Baltimore MD, US
Amir Rattner - Baltimore MD, US
Noah F. Shroyer - Houston TX, US
Nanda Singh - Salt Lake City UT, US
Philip Smallwood - Woodbine MD, US
Hui Sun - Baltimore MD, US
Kent L. Anderson - Houston TX, US
Michael Dean - Frederick MD, US
Mark Leppert - Salt Lake City UT, US
Richard A. Lewis - Houston TX, US
Yixin Li - Houston TX, US
James R. Lupski - Houston TX, US
Jeremy Nathans - Baltimore MD, US
Amir Rattner - Baltimore MD, US
Noah F. Shroyer - Houston TX, US
Nanda Singh - Salt Lake City UT, US
Philip Smallwood - Woodbine MD, US
Hui Sun - Baltimore MD, US
Assignee:
Baylor College of Medicine - Houston TX
International Classification:
C12N 1/21, C12N 15/11, C12N 15/63, C12N 5/10, C12N 1/19
US Classification:
435348, 435349, 435358, 435363, 435367, 4352523, 43525231, 43525233, 43525234, 4352542, 43525421, 4353201, 536 231
Abstract:
The present invention provides nucleic acid and amino acid sequences of an ATP binding cassette transporter and mutated sequences thereof associated with macular degeneration. Methods of detecting agents that modify ATP-binding cassette transporter comprising combining purified ATP binding cassette transporter and at least one agent suspected of modifying the ATP binding cassette transporter an observing a change in at least one characteristic associated with ATP binding cassette transporter. Methods of detecting macular degeneration is also embodied by the present invention.